A new board member from an established drug/biotech company would be a great addition. It may also be a clue to the below comments from Leo.
Cellceutix has signed an agreement with a division of one of the largest U.S. pharmaceutical companies for testing Brilacidin as a component of certain implanted devices as a means to prevent infection.
News 
Market Data 
Discover 
